KDR and neoplasm: The VEGF and VEGFR expression differences are also in line with the observed dissimilarity in sunitinib tumor responses: treatment leads to major necrosis in NU12 tumors (high expression VEGFR1) and stabilization of SK-RC-52 tumors (lower VEGFR1) [8].